Article
Rapid Phenotypic Screening of Lysine-Degrading Probiotics via FTIR Spectroscopy: Toward Precision Therapy for Hyperlysinemia.
ACS synthetic biology - 20 Feb 2026
Zhang Yiqing, Wu Mingyu, Li Xueling, Geng Feng, Lü Junhong, Wang Yadi
Abstract excerpt
Hyperlysinemia is a life-threatening metabolic disorder that requires the continuous clearance of lysine. Engineered probiotics capable of degrading lysine in the gut represent a promising therapeutic strategy. However, the introduction of heterologous metabolic pathways can impose a substantial fitness burden on the bacterial host, potentially compromising the therapeutic efficacy. Current screening methods fail...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
